• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number D321-KIT
Device Problems Fluid/Blood Leak (1250); Device Displays Incorrect Message (2591); Misassembly by Users (3133)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/21/2015
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.A batch record review of kit lot d321 was conducted.There were no non-conformances related to the complaint.This lot met all release requirements.The uvadex lot number was not provided.However, a review of all uvadex lots manufactured since january 2013 was performed.No trends or noncoformances related to the complaint were noted.Trends were reviewed for complaint categories, alarm #1: air detected, alarm #17: return pressure, alarm #18: system pressure, clot observed, and protocol: assembly or operation.No trend was detected for complaint categories, alarm #17: return pressure, clot observed, and protocol: assembly or operation.A downward trend was detected for complaint categories, alarm #18: system pressure and alarm #1: air detected.A corrective and preventive action was initiated for complaint categories, alarm #17: return pressure and alarm #1: air detected, and is now closed.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).Device not returned to manufacturer.
 
Event Description
The customer called to report system pressure alarms x2 after elutriation with 1858ml of whole blood processed.The customer confirmed that there was over 200ml in the treatment bag and it contained some red cells.The customer was given instructions on how to start photoactivation.A return pressure alarm occurred.A few minutes into photoactivation, an air detected alarm occurred with collapsed tubing.No air was seen.The customer noted that the centrifuge bowl and return line were clotted.The customer then saw that the anticoagulant (ac) and saline spikes were in the wrong fluids; the ac line was spiked to the saline bag and the saline line was spiked to the ac bag.The customer disconnected both lines from the patient.The customer confirmed that there was no clotting in the treatment bag and chose to continue with photoactivation.The customer was advised to consult with the patient's provider.The customer was given instructions on how to give a manual return of the treatment bag contents once photoactivation was completed.The customer was advised to monitor the patient's vital signs.The customer was also advised to reinfuse the treatment bag slowly through a blood infusion set, and to check for symptoms of hypocalcemia due to the increased anticoagulant volume.The customer verbalized understanding.The estimated patient blood loss and anticoagulant volume reinfused was discussed with the customer and the customer was referred to technical bulletin #8 of the operator's manual.No service order was generated.On (b)(6) 2015, the customer stated that the treatment was completed and the patient tolerated it well with no side effects.They had disconnected all access from the patient and then started a new line in order to return the contents of the treatment bag.The doctor was notified of the patient's status right after treatment.The patient had his next treatment the following morning and did well.The customer has elected not to return the kit for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC
west chester PA
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 bailey ave
buffalo NY 14211
Manufacturer Contact
dianna inguanzo
10 north high street
suite 300
west chester, PA 19380
MDR Report Key5068436
MDR Text Key26744396
Report Number2523595-2015-00244
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Nurse
Report Date 08/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Nurse
Device Expiration Date04/01/2017
Device Lot NumberD321-KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/10/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age68 YR
Patient Weight62
-
-